Caricamento...
CRISPR screens are feasible in TP53 wild‐type cells
A recent study by Haapaniemi et al (2018) reported that intact p53 signaling hampers CRISPR‐based functional genomic screens. Brown et al report good performance of genome‐scale screens in TP53 wild‐type cells and reiterate best practices for CRISPR screening. [Image: see text]
Salvato in:
| Pubblicato in: | Mol Syst Biol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686785/ https://ncbi.nlm.nih.gov/pubmed/31464370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20188679 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|